Tablet Production: From Compound to Tablet and Where Merlin Fits In
Developing a new medicine is an expensive process. $1.3 billion US Dollars, or £936 million Pounds, is the current average cost for bringing new medicines into the global marketplace. (1)
Producing a new drug formulation can be a huge financial risk for pharmaceutical companies, as a number of challenges can occur during the development process which can be costly. It is essential that tablet formulations undergo strict and unbiased testing to help reduce the risks during manufacture.
There are many stages that stand between an initial pharmaceutical compound, and a lifesaving medicine approved by the regulators for distribution to end-users. Examples of regulators are the American Food and Drug Administration (FDA), the British Medicines and Healthcare products Regulatory Agency (MHRA) and the European Medicines Agency (EMA).